# Exagen Inc.: Form 8-K, filed Nov 17, 2023

- Company: [Exagen Inc.](/companies/xgn.md) (CIK 1274737)
- Form: 8-K
- Filed: 2023-11-17
- Accepted by EDGAR: Nov 17, 2023, 16:30 ET
- Period: 2023-11-17
- Accession: 0001274737-23-000105
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000105/exdx-20231117.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000105/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1274737/000127473723000105/exdx-20231117.htm

Filed Nov 17, 2023.
Source: SEC EDGAR, the filing index for accession 0001274737-23-000105. Last ingested by Listed: Nov 15, 2026, 04:30 ET. No prices; not investment advice.
